A detailed history of Guardian Wealth Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Guardian Wealth Advisors, LLC holds 5,418 shares of NVO stock, worth $267,974. This represents 0.03% of its overall portfolio holdings.

Number of Shares
5,418
Previous 3,130 73.1%
Holding current value
$267,974
Previous $217,000 71.89%
% of portfolio
0.03%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$58.08 - $81.05 $132,887 - $185,442
2,288 Added 73.1%
5,418 $373,000
Q1 2025

May 15, 2025

BUY
$69.3 - $90.95 $50,311 - $66,029
726 Added 30.2%
3,130 $217,000
Q4 2024

Feb 14, 2025

BUY
$85.0 - $120.04 $204,340 - $288,576
2,404 New
2,404 $206,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $112B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Guardian Wealth Advisors, LLC Portfolio

Follow Guardian Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guardian Wealth Advisors, LLC , based on Form 13F filings with the SEC.

News

Stay updated on Guardian Wealth Advisors, LLC with notifications on news.